NCT02726607 is a NA clinical trial of HIV Infant Tracking System (HITSystem) 2.0 in HIV, sponsored by University of Kansas Medical Center.

Who is sponsoring NCT02726607?

NCT02726607 is sponsored by University of Kansas Medical Center.

What drugs are being tested in NCT02726607?

Interventions in NCT02726607: HIV Infant Tracking System (HITSystem) 2.0, Standard of PMTCT care.

Is NCT02726607 still recruiting?

NCT02726607 is currently completed. Last updated 1 April 2020.

Last reviewed 2020-04-01 · How we verify

NCT02726607

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Adapting the HITSystem to Support Prevention of Mother-to-child HIV Transmission

Completed NA Last updated 1 April 2020

What this trial tests

NA trial testing HIV Infant Tracking System (HITSystem) 2.0 in HIV in 157 participants. Completed in 20 March 2020.

Timeline

15 August 2015

Primary endpoint
30 July 2019

20 March 2020

Quick facts

Lead sponsor	University of Kansas Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	157
Start date	15 August 2015
Primary completion	30 July 2019
Estimated completion	20 March 2020
Sites	3 locations across Kenya, United States

Drugs / interventions tested

HIV Infant Tracking System (HITSystem) 2.0
Standard of PMTCT care

Conditions studied

HIV — all drugs for HIV →

Sponsor

University of Kansas Medical Center

Who can join

18 and older, female only, with HIV. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to modify the HITSystem to engage and retain HIV+ pregnant women before, during and after delivery and evaluate the HITSystem impact on prevention of mother-to-child transmission (PMTCT) related behaviors and outcomes. HITSystem 2.0 intervention will support a range of PMTCT outcomes including retention in care, ART adherence, and integration of maternal and pediatric HIV services in low-resource settings.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

A Pilot Study to Evaluate the Impact of the HIV Infant Tracking System (HITSystem 2.0) on Priority Prevention of Mother-to-Child Transmission (PMTCT) Outcomes.
Finocchario-Kessler S, Brown M, Maloba M, Nazir N, et al · · 2021 · cited 11× · PMID 33709212 · DOI 10.1007/s10461-021-03204-0
Adapting the HIV Infant Tracking System to Support Prevention of Mother-to-Child Transmission of HIV in Kenya: Protocol for an Intervention Development Pilot Study in Two Hospitals.
Finocchario-Kessler S, Maloba M, Brown M, Gautney B, et al · · 2019 · cited 5× · PMID 31199305 · DOI 10.2196/13268

Verify or expand the search:

Other recruiting trials for HIV

Currently open trials in the same condition.

NCT06705478 — Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disor · Phase 2 · recruiting
NCT07221214 — GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV · Phase 2 · recruiting
NCT07226128 — The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV · NA · recruiting
NCT07390474 — Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA i · Phase 1 · recruiting
NCT07390955 — A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1 · Phase 1 · recruiting

Other University of Kansas Medical Center trials

Trials by the same sponsor.

NCT06636214 — Adapting Changing Talk: Online (CHATO) to CHATO-Inclusive · NA · not yet recruiting
NCT07528963 — KanSurvive 2.0: Testing Enhanced Models of Cancer Survivorship Care for Rural Cancer Survivors in Primary Care Practice · NA · enrolling by invitation
NCT07463755 — Low-Fidelity Driving Simulator Training in Parkinson's Disease. · NA · not yet recruiting
NCT07420621 — Preliminary Effectiveness of Enhanced Text Message + Incentives · NA · recruiting
NCT07491510 — Improving Prenatal Care to Reduce Early Onset Preeclampsia in Low-Income · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02726607 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Kansas Medical Center
Last refreshed: 1 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02726607.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing